Agreement - July 2, 2015
Targovax, Oncos Strike Deal
Norwegian Targovax has entered an agreement with the shareholders of Finnish clinical-stage biotechnology company Oncos Therapeutics to acquire the shares of Oncos with settlement in Targovax shares. After the transaction, the shareholders of Oncos will own 50 per cent of Targovax. The new company already has received indications of interest from leading institutional investors, including a 26 […]
Pharma Business - March 30, 2015
Karolinska Sells Axelar Shares
Karolinska Development AB has sold its shares in Axelar AB to The Foundation for Baltic and East European Studies (Östersjöstiftelsen). The agreement is in keeping with Karolinska Development’s current strategy. “Karolinska Development’s new strategy includes focusing on our strategic portfolio, an increased emphasis on leadership within our portfolio companies, proactively syndicating our investments with […]
Acquisition - March 24, 2015
Skavak Buys Nordic Nanovector Shares
Skavak Invest AS, a company controlled by a close associate of Tone Kvåle, who is the chief financial officer of Nordic Nanovector ASA, purchased 3,000 shares in Nordic Nanovector ASA at an average share price of NOK 35 per share. Following the transaction and completion of the offering, Tone Kvåle will own 38,292 shares and […]
